These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1146 related articles for article (PubMed ID: 9193196)
1. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group. Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196 [TBL] [Abstract][Full Text] [Related]
2. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group. Arvanitis LA; Miller BG Biol Psychiatry; 1997 Aug; 42(4):233-46. PubMed ID: 9270900 [TBL] [Abstract][Full Text] [Related]
3. ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL Study Group. Borison RL; Arvanitis LA; Miller BG J Clin Psychopharmacol; 1996 Apr; 16(2):158-69. PubMed ID: 8690831 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials. Buckley PF Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183 [TBL] [Abstract][Full Text] [Related]
5. ICI 204,636, a novel, atypical antipsychotic: early indication of safety and efficacy in patients with chronic and subchronic schizophrenia. Fabre LF; Arvanitis L; Pultz J; Jones VM; Malick JB; Slotnick VB Clin Ther; 1995; 17(3):366-78. PubMed ID: 7585841 [TBL] [Abstract][Full Text] [Related]
6. A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, 'Seroquel') and haloperidol in schizophrenia. Copolov DL; Link CG; Kowalcyk B Psychol Med; 2000 Jan; 30(1):95-105. PubMed ID: 10722180 [TBL] [Abstract][Full Text] [Related]
7. A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy. Kane JM; Correll CU; Goff DC; Kirkpatrick B; Marder SR; Vester-Blokland E; Sun W; Carson WH; Pikalov A; Assunção-Talbott S J Clin Psychiatry; 2009 Oct; 70(10):1348-57. PubMed ID: 19906340 [TBL] [Abstract][Full Text] [Related]
8. Quetiapine : A Review of its Use in Schizophrenia. Gunasekara NS; Spencer CM CNS Drugs; 1998 Apr; 9(4):325-40. PubMed ID: 27521016 [TBL] [Abstract][Full Text] [Related]
9. Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. Seroquel Trial 48 Study Group. McManus DQ; Arvanitis LA; Kowalcyk BB J Clin Psychiatry; 1999 May; 60(5):292-8. PubMed ID: 10362435 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of quetiapine in adolescents with schizophrenia investigated in a 6-week, double-blind, placebo-controlled trial. Findling RL; McKenna K; Earley WR; Stankowski J; Pathak S J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):327-42. PubMed ID: 23083020 [TBL] [Abstract][Full Text] [Related]
11. Quetiapine in schizophrenia: onset of action within the first week of treatment. Small JG; Kolar MC; Kellams JJ Curr Med Res Opin; 2004 Jul; 20(7):1017-23. PubMed ID: 15265246 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders. McConville BJ; Arvanitis LA; Thyrum PT; Yeh C; Wilkinson LA; Chaney RO; Foster KD; Sorter MT; Friedman LM; Brown KL; Heubi JE J Clin Psychiatry; 2000 Apr; 61(4):252-60. PubMed ID: 10830145 [TBL] [Abstract][Full Text] [Related]
13. A failed 6-week,randomized, double-blind, placebo-controlled study of once-daily extended release quetiapine fumarate in patients with acute schizophrenia: lessons learned. Cutler AJ; Tran-Johnson T; Kalali A; Aström M; Brecher M; Meulien D Psychopharmacol Bull; 2010; 43(4):37-69. PubMed ID: 21240151 [TBL] [Abstract][Full Text] [Related]
14. A comparison of bd and tid dose regimens of quetiapine (Seroquel) in the treatment of schizophrenia. King DJ; Link CG; Kowalcyk B Psychopharmacology (Berl); 1998 May; 137(2):139-46. PubMed ID: 9630000 [TBL] [Abstract][Full Text] [Related]
15. Long-Term use of quetiapine in elderly patients with psychotic disorders. Tariot PN; Salzman C; Yeung PP; Pultz J; Rak IW Clin Ther; 2000 Sep; 22(9):1068-84. PubMed ID: 11048905 [TBL] [Abstract][Full Text] [Related]
16. Seroquel (ICI 204 636), a putative "atypical" antipsychotic, in schizophrenia with positive symptomatology: results of an open clinical trial and changes of neuroendocrinological and EEG parameters. Wetzel H; Szegedi A; Hain C; Wiesner J; Schlegel S; Benkert O Psychopharmacology (Berl); 1995 May; 119(2):231-8. PubMed ID: 7659771 [TBL] [Abstract][Full Text] [Related]
17. Comparison of quetiapine and risperidone in the treatment of schizophrenia: A randomized, double-blind, flexible-dose, 8-week study. Zhong KX; Sweitzer DE; Hamer RM; Lieberman JA J Clin Psychiatry; 2006 Jul; 67(7):1093-103. PubMed ID: 16889453 [TBL] [Abstract][Full Text] [Related]
18. Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms. Riedel M; Spellmann I; Strassnig M; Douhet A; Dehning S; Opgen-Rhein M; Valdevit R; Engel RR; Kleindienst N; Müller N; Möller HJ Eur Arch Psychiatry Clin Neurosci; 2007 Sep; 257(6):360-70. PubMed ID: 17629731 [TBL] [Abstract][Full Text] [Related]
19. Long-term maintenance therapy with quetiapine versus haloperidol decanoate in patients with schizophrenia or schizoaffective disorder. Glick ID; Marder SR J Clin Psychiatry; 2005 May; 66(5):638-41. PubMed ID: 15889952 [TBL] [Abstract][Full Text] [Related]
20. Quetiapine alone and added to a mood stabilizer for serious mood disorders. Sajatovic M; Brescan DW; Perez DE; DiGiovanni SK; Hattab H; Ray JB; Bingham CR J Clin Psychiatry; 2001 Sep; 62(9):728-32. PubMed ID: 11681770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]